CELLOREON

CELLOREON is pioneering the next generation of human organoids for drug discovery. Using synthetic microgels, we create various organoids such as cardiac, kidney, bone marrow, neural, or retina that are fully reproducible, animal-free, and automation-ready. Our technology overcomes the limitations of animal-derived materials like Matrigel, ensuring consistency, scalability, and ethical compliance. Unlike conventional systems, our organoids develop without forming necrotic cores and exhibit homogeneous differentiation across the entire structure, making them more physiologically relevant and reliable. By combining advanced biomaterials with automated workflows and data analysis, CELLOREON accelerates biomedical research, reduces costs, and improves translation for society and human health. From personalized medicine to high-content drug screening, we empower scientists and pharmaceutical companies with a faster, more reliable, and ethically superior organoid technology platform.